Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

China flag China · Delayed Price · Currency is CNY
15.90
+0.40 (2.58%)
Jul 3, 2026, 3:00 PM CST
Market Cap4.54B +64.4%
Revenue (ttm)2.89B +28.1%
Net Income-114.97M
EPS-0.39
Shares Out 285.46M
PE Ration/a
Forward PEn/a
Dividend0.07 (0.44%)
Ex-Dividend DateJun 23, 2025
Volume14,726,200
Open15.66
Previous Close15.50
Day's Range15.44 - 16.08
52-Week Range10.17 - 32.27
Beta-0.17
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHA:600513

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, dapoxetine hydrochloride, milrinone injection, aprilite, ebastine tablets, felodipine tablets, tadalafil, and betasine besylate tablets, as well as danazol suppositories, drapavelin hydrochloride injection, and terfenadine tablets. It also provide... [Read more]

Sector Healthcare
Founded 1999
Employees 2,131
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600513
Full Company Profile

Financial Performance

Financial Statements